Nano Biz...in depth... im detail

 

Wall Street Reporter Issues a New Interview With
MFIC CEO, Irwin Gruverman; Full Interview
Available at WSR Website

NEWTON, Mass.--(BUSINESS WIRE) -At the request of the Wall Street Reporter Magazine, Irwin Gruverman, CEO and Chairman of MFIC Corporation (OTCBB: MFIC) was interviewed by Scott Banks on the subject of MFIC's recent completion of its successful financial restructuring and its ongoing contribution to American manufacturing excellence in a range of products. MFIC provides the leading edge high performance mixing and formulation equipment available to the biotech, pharmaceuticals, coatings, paint, chemical and food industries.

The interview can be heard online at www.wallstreetreporter.com and serves to familiarize investors with MFIC, giving them insight into the background, performance, products and management team of the Company. The in-depth interviews conducted by WSR are geared toward sophisticated investors who require unbiased, unscripted first-hand perspective to assist them in making informed investment decisions. The interview can be retrieved on the site by scrolling down the right-hand column of companies covered until you locate MFIC which is listed under the OTCBB section.

Mr. Gruverman focussed on the financial re-engineering of MFIC which occurred in the last few months. As described in recent press releases, the Morehouse-COWLES Division assets were sold to allow a focus on the core Microfluidizer systems business; restructured bank lines moved from an asset-based line which limited investment in new initiatives to a four-year term loan and cash-flow based credit line; a completed a PIPE financing to raise $2.9MM net, with Warrants outstanding now which could raise an additional $3MM. The company is now out of debt and can commit more than $2MM to new initiatives.

Proceeds will be committed to several programs. Mr. Gruverman stated "We have hired and will continue to seek key people in engineering, marketing/sales and R&D functions. We are initiating several exciting projects using our Multiple Stream Mixer/Reactor (MMR) technology, and plan a multi-year effort to establish MFIC as the leader in nanotechnology materials manufacturing. Marketing and development of systems and applications will be included in this effort.

Our core Microfluidizer(R) processing system business will commit to increase our market penetration from the few percent we now enjoy to several times that level. We plan to have industry specialists to find applications in many industries for our unique high pressure fluid processing technology."

The Board of Directors includes individuals with banking, marketing, technical and financing expertise and is active in enhancing a skilled management team in its performance.

Marketing and sales are centralized and a strong core team leads an extensive network of agents and distributors in North America, Europe and Asia. About 80% of Microfluidizer processor system sales are to the pharmaceutical and biotech industries. Most sales are to Fortune 500 companies.

"We have restarted our Investor Relations efforts to create an awareness of our new position as a financially-sound business with a strong core and a new proprietary MMR component with the potential to propel us to a much higher value level over time," commented Mr. Gruverman. "We are seeking to resume listing on a National exchange."

Management believes that this release contains forward-looking statements that are subject to certain risks and uncertainties including statements relating to the Company's ability to achieve attain and/or increase operating profitability, and/or to achieve and/or improve net income profitability. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties that could cause actual results achieved by the Company to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that the actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including but not limited to, the following risks and uncertainties: (i) whether the performance advantages of the Company's Microfluidizer(R) materials processing equipment will be realized commercially or that a commercial market for the equipment will continue to develop, (ii) whether the Company will have access to sufficient working capital through continued and improving cash flow from sales and ongoing borrowing availability, the latter being subject to the Company's ability to comply with the covenants and terms of the Company's loan agreement with its senior lender, and (iii) whether the Company will be able to produce and make timely delivery of equipment under accepted purchase orders and outstanding sales quotations.

MFIC CORPORATION

MFIC Corporation, through its Microfluidics Division, provides patented and proprietary high performance Microfluidizer(R) materials processing equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid structures available, and has provided manufacturing systems for nanoparticle products for more than 15 years. The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to MFIC equipment customers.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

 

 

 

 



Nano Biz